0.11, 1.81; p=0.027) were found in AVSc subjects than in controls, with no differences in AIx (MD: 0.76%; 95%CI: -0.97, 2.49; p=0.389). In Meta-regression analyses body mass index and triglycerides levels have an impact on the difference in IMT between cases and controls, while male gender and smoking habit were associated with the difference in the prevalence of CPs between the two groups.
Introduction
Aortic valve sclerosis (AVSc) has become, in the last decade, very popular among clinicians and scientists. This interest is due to the strong correlation that this condition has with aortic valve stenosis, coronary artery events, stroke, cardiovascular mortality and all-cause mortality [1] .
AVSc is generally characterized by focal or diffuse aortic valve thickening with or without increased echogenicity and without any significant hemodynamic effects [2] . AVSc is identified by EAE/ASE and AHA/ACC guidelines as unrestricted leaflet opening with a maximal transvalvular velocity of <2.0 m/s [3] and < 2.5 m/s [4] on Doppler echocardiographic measurement, respectively.
The prevalence of this condition is estimated around 30% in patients older than 65 years and up to 40% in those older than 75 years [2] . In addition, a strong correlation between AVSc and conventional vascular risk factors (VRFs) has been reported in several studies [5] [6] [7] . In particular, the association with age, male gender, hypertension, hyperlipidemia, diabetes and smoking suggests that AVSc might be considered an atherosclerosis-like process [2, 7] . A recent study by Coffey et al. [1] has reported that AVSc patients have a low rate of progression (≈ 2% every year) to symptomatic aortic valve stenosis. In spite of the dramatic increase in the literature of the field, whether AVSc is just a marker of valve degeneration rather than a generalized vascular disease is still matter of debate [1] .
The recent advancement of imaging modalities has made possible the non-invasive assessment of a number of morphological and functional aspects of atherosclerosis disease, in all phases of its development. Carotid intima-media thickness (cIMT), carotid plaques (CPs), flow-mediated dilation (FMD), aortic pulse wave velocity (PWV) and aortic augmentation index (AIx) are all examples of these non-invasive arterial morphology or functional modalities. Convincing evidence are now available showing that each one of these variables is able to add prognostic information over and above conventional VRFs and all are independent predictors of CV events [8] [9] [10] [11] [12] [13] [14] . For these reason all these variables are now widely accepted as surrogate markers of subclinical and even clinical atherosclerosis. During recent years, a series of single studies have investigated the association between AVSc and these markers of atherosclerosis proving accelerated atherosclerosis [15] , impaired endothelial function [16, 17] , and increased arterial stiffness [18] in patients with aortic valve sclerosis. However, no one has addressed this issue by using a meta-analytic approach.
To provide a comprehensive overview of these relationships, we performed a systematic review with meta-analysis of literature studies to evaluate the association of aortic valve sclerosis and major markers of subclinical atherosclerosis.
Methods
A protocol for this review was prospectively developed, detailing the specific objectives, the criteria for study selection, the approach to assess study quality, the outcomes, and the statistical methods.
Search strategy
To identify all available studies, a detailed search pertaining to aortic valve sclerosis and markers of CV risk (i.e. IMT, FMD, NMD, PWV, AIx) was conducted according to Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA ) guidelines [19] . A systematic search was 
Data extraction and quality assessment
According to the pre-specified protocol, all studies evaluating the impact of aortic valve sclerosis on the markers of CV risk were included. Case-reports, case-series without a control group, reviews and animal studies were excluded. To be included in the analysis, a study had to provide values (means with standard deviation) of at least one variable among the following: common carotid artery IMT (IMT), brachial artery FMD, carotid-femoral PWV, aortic AIx. Studies reporting the prevalence of CPs were also included. We included only studies defining aortic valve sclerosis as focal or diffuse leaflet thickening with or without calcification, with normal valve excursion, and peak Doppler flow velocity of < 2.0 m/s [3, 4, 20] . In each study, data regarding sample size, major clinical and demographic variables, values of IMT, FMD, PWV and AIx and prevalence of CPs in patients with AVSc and healthy controls were extracted.
Formal quality score adjudication was not used, since previous investigations failed to demonstrate its usefulness. [21] Statistical analysis and risk of bias assessment Statistical analysis was carried out using Comprehensive Meta-analysis [Version 2, Biostat,
Differences among cases and controls were expressed as mean difference (MD) with pertinent 95% confidence intervals (95%CI) for continuous variables, and as Odds Ratio (OR) with pertinent 95% CI for dichotomous variables.
IMT has been expressed in millimeters (mm), FMD and AIx as percentage (%), and PWV as mm per second (mm/s).
The overall effect was tested using Z scores and significance was set at P <0.05. Statistical heterogeneity between studies was assessed with chi square cochran's Q test and with I 2 statistic, which measures the inconsistency across study results and describes the proportion of total variation in study estimates that is due to heterogeneity rather than sampling error. In detail, I 2 values of 0%
indicates no heterogeneity, 25% low, 25-50% moderate, and 50% high heterogeneity [22] .
Publication bias was assessed by the Egger's test and represented graphically by funnel plots of the standard difference in means versus the standard error. Visual inspection of funnel plot asymmetry was performed to address for possible small-study effect, and Egger's test was used to assess publication bias, over and above any subjective evaluation. A p < 0.10 was considered statistically significant [23] . In case of a significant publication bias, the Duval and Tweedie's trim and fill method was used to allow for the estimation of an adjusted effect size [24] . In order to be as conservative as possible, the random-effect method was used for all analyses to take into account the variability among included studies.
Meta regression analyses
Differences among included studies may be affected by demographic variables (age, male gender) and traditional CV risk factors (hypertension, smoking habit, diabetes mellitus, obesity). 
Results

Study characteristics
After excluding duplicate results, the search retrieved 176 articles. Of these, 160 were excluded because they were off the topic after scanning the title and/or the abstract or because they were reviews, comments, case reports or because they lacked of data of interest. Three studies were excluded after full-length paper evaluation.
Thus, 13 studies on 1086 AVSc patients and 2124 controls were included in the final analysis (Supplemental Figure 1 ).
Major characteristics of included studies are shown in Table The heterogeneity among studies was significant (I 2 = 95.9%; p < 0.0001) but, after excluding one study at a time, we found that all the results were confirmed (data not shown). Also after excluding the study of Yamaura et al. [27] , that reported the highest MD between AVSc patients and controls, the difference in IMT remained significant without heterogeneity (MD: 0.17 mm; 95%CI: 0.13, 0.21; p < 0.0001, I 2 = 0%; p = 0.48). Five studies [15, 16, [28] [29] [30] , showed an increased prevalence of CPs in 941 AVSc patients as compared to 1103 controls, with an OR of 4.06 (95%CI:
2.38, 6.93; p < 0.001, Figure 1 panel B) . The heterogeneity among studies was significant (I 2 = 65.3%; p = 0.021). Also, in this case, after excluding one study at a time, we found that all the results were confirmed (data not shown). In addition, after excluding the study of Schonenberger et al. [29] , that reported the highest OR between AVSc patients and controls, the same difference in the prevalence of carotid plaque was confirmed (OR: 3.62; 95%CI: 2.18, 6.01; p < 0.001, I 2 = 64.8%; p = 0.036). Also excluding studies [16, 27] in which cases and controls were not age-matched, both the difference in IMT and in CPs prevalence were confirmed (MD: 0.18 mm; 95%CI: 0.11, 0.26; p < 0.001, I 2 = 27.5%; p = 0.24 and OR: 3.98; 95%CI: 2.10, 7.55; p < 0.001, I 2 = 73.2%; p = 0.011).
Flow-Mediated Dilation (FMD)
Two studies [16, 17] , evaluating a total of 63 cases and 146 controls, showed a significantly lower FMD in AVSc patients as compared to controls (MD: -4.48; 95%CI: -7.23, -1.74; p = 0.001, Figure   2 ) with a significant heterogeneity among studies (I 2 = 73.7%; p = 0.0051).
Pulse wave velocity (PWV)
Four studies [16, 18, 25, 31] showed a significantly higher PWV in the 230 AVSc patients as without heterogeneity among studies (I 2 = 25.9%; p = 0.249). Of interest, after excluding the study by Erdogan et al. [16] , that enrolled non aged-matched cohorts, the lack of difference in AIx values between AVSc patients and controls was consistently confirmed (MD: 0.99 mm; 95%CI: -1.07, 3.06; p = 0.347, I 2 = 41,5%; p = 0.162).
Publication bias
Funnel plots of effect size versus standard error for studies evaluating IMT, CPs, PWV and AIx were rather symmetrical and the Egger's test showed the absence of publication bias (Egger's p = 0.541; p = 0.500; p = 0.147 and p = 0.521, respectively, Supplemental Figure 2 ).
Meta-regression analyses
Regression models (Figure 4) showed that BMI and triglycerides levels significantly impacted on the difference in IMT between AVSc patients and controls (Z= -7.99, p < 0.001 and Z = -11.85, p < 0.001, respectively), while male gender and smoking habit impacted on the difference in the prevalence of CPs (Z = -2.08, p = 0.037 and Z = 2.14, p = 0.032, Figure 5 ). All the other covariates (see methods section) did not impact on any subclinical atherosclerosis marker considered.
Discussion
Results of the present meta-analysis consistently show that AVSc is associated with an increased carotid IMT, with a high prevalence of CPs, with an impaired flow-mediated dilation (FMD) and with a high pulse wave velocity (PWV). Our findings are strengthened by sensitivity analyses, which consistently confirm results of primary analyses. Regression models were used to further refine results, suggesting major clinical variables potentially impacting on the difference in carotid IMT and in the prevalence of CPs between AVSc patients and controls. Overall, these data clearly suggest that patients with an increased CV risk due to the presence of signs of subclinical atherosclerosis deserve to be evaluated for the presence of AVSc, which, in turn, may be considered as an additional CV risk factor. Accordingly, previous published studies reported an increased risk of major CV events and CV death in patients with AVSc [1] .
In order to provide a comprehensive overview of the relationship between AVSc and subclinical atherosclerosis, in the present meta-analysis, which includes more than 2800 subjects, all the major recognized markers of CV risk were taken into account.
Both, IMT and CPs, are recognized marker of subclinical atherosclerosis strongly associated with and increased CV risk [34] . A significantly decreased FMD and an increased PWV were found in AVSc patients [17] . The association between AVSc and Aix, the only indirect atherosclerosis marker took into account, showed a positive but not significant trend. The lack of significance could be explained by the method used to calculate this index, being AIx just an indirect measure of aortic arterial stiffness. In addition, a series of CV risk factors, particularly aging, are known to impact this variable [35] . The lack of difference in AIx values between AVSc patients and controls was consistently confirmed also after specifically analysing studies enrolling age-matched cohorts.
To strengthen our results, it would have been useful to assess also the prevalence of CV events among AVSc subjects and healthy controls. Unfortunately, this has not been possible because most of the studies considered have specifically excluded patients with clinically proven coronary artery disease, history of myocardial infarction and/or cerebrovascular accidents.
Overall, patients with AVSc have an increased likelihood to present signs of subclinical atherosclerosis and the clinical relevance of our results becomes evident considering that the risk of myocardial infarction increases of 43% every 0.163 mm increase in carotid IMT [36] . An even better predictor of CV events than IMT is represented by the prevalence of CPs [34, 37] . In addition, our results on FMD further confirm the presence of accelerated atherosclerosis in patients with
AVSc. The rationale for the association between FMD and CV prognosis is the assumption that FMD reflects endothelium-dependent dilation and, in turn, nitric oxide (NO) bioavailability [38] .
Endothelium-derived NO possesses several anti-atherogenic and plaque stabilizing properties, including inhibition of cell growth and proliferation, regulation of vascular tone and arterial wall stress, inhibition of leukocyte and platelet adhesion, and antithrombotic and fibrinolytic properties [37] . In keeping with this, it has been documented that each 1% decrease in FMD is associated with a 12% increase of CV events [39] . Furthermore, we have to consider that the risk of major CV events increases of about 14% each 1 m/s increase in PWV [40] .
In our meta-regression analysis BMI and triglycerides levels impacted positively on the difference in IMT between AVSc patients and controls, whereas male gender impacted inversely on the difference in the prevalence of CPs between the two groups. These results can be due to the direct pro-atherogenic effects of obesity, hypertriglyceridemia and male gender. On the other hand, the fact that the associations observed remain significant also after adjustment for these covariates suggests that, in the presence of AVSc, sub-clinical atherosclerosis can be found also in patients without these CV risk factors. Whether the concomitant presence of AVSc and markers of subclinical atherosclerosis, may add in risk stratification over and above the possible common effects of conventional VRFs and whether a preventive strategy may be useful also for the control of AVSc progression remains to be established. Furthers ad hoc studies specifically designed to better understand the meaning of these associations are needed.
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Some potential limitations of our study need to be discussed. First, the studies included in our metaanalysis have different inclusion and exclusion criteria and patients included had concomitant CV risk factors (hypertension, smoking, obesity, diabetes mellitus, and hyperlipidemia). With the metaregression approach, we have attempt to address this issue but data available have allowed to adjust the analyses for some, but not all the potential confounders. Second, heterogeneity among the studies was generally significant. However, all results have been confirmed without heterogeneity after the exclusion of one study at a time or excluding studies enrolling non age-matched patients.
Thus, although unable to conclusively ascertain all potential sources of heterogeneity, we are confident that its impact on results can be considered almost negligible. The last potential study limitation lies in the definition of CPs, which widely varied among studies considered. Despite this, the association with AVSc was consistently confirmed for all evaluated outcomes.
In conclusion, our meta-analysis shows that AVSc is significantly associated with subclinical atherosclerosis and endothelial dysfunction. These results strongly suggest that valve degeneration and atherosclerosis might share some etiopathological mechanisms and/or predisposing factors. On this basis, an echocardiographic assessment the aortic valve status would be desirable whenever an altered marker of subclinical atherosclerosis is found.
Highlights
-Aortic valve sclerosis (AVSc) is correlated with classical risk factors for cardiovascular disease and it is considered an atherosclerosis-like process.
-The association of AVSc with markers of cardiovascular risk is poorly studied and widely discussed.
-We found that AVSc is associated with an increased subclinical atherosclerosis and with impaired endothelial function; all being recognized as major predictors of cardiovascular risk. Note: Funnel plots of effect size versus standard error for studies evaluating flow mediated dilation in aortic valve sclerosis (AVSc) patients and controls was not produced because less than 3 studies evaluated this outcome.
